Dr Lal Path Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dr lal path lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dr Lal Path Lab Today - Breaking & Trending Today

Nifty Pharma: Aditya Arora is bullish on Nifty Pharma, sees last leg of rally in high beta counters post Budget

Aditya Arora is tracking Nifty Pharma and mentions good moves in Cipla, Dr Lal Path Lab, and Metropolis. The chart structure of many pharma counters has improved. On the flip side, many financials or cyclical stocks appear to be topping out. Indiabulls Housing Finance is breaking out with volume support. Aditya Arora recommends buying it at Rs 215 with a stop loss at Rs 190 and a target of Rs 230 to 250. ....

Uttar Pradesh , Aditya Arora , Indian School Of Business , Offering College , Dr Lal Path Lab , Bank Nifty , Nifty Pharma Index , Leadership Excellence , Executive Officer , Operations Officer , Indiabulls Housing , Indiabulls Housing Finance , Nifty Pharma , High Beta Counters , Pharma Counters , Cyclical Stocks , Expert View , Stock Market , Et Now ,

stocks to buy: Titan and Balrampur Chini are high conviction buys for Hemang Jani. Here's why

“I would buy real estate stocks if there is a small correction of about 5%, 10%. These are all high beta stocks. Interest rates have not really gone down. I am a little surprised that even at higher interest rates, these kinds of numbers are being delivered. So I want to have some exposure. But purely from a momentum perspective, on a dip.” ....

Uttar Pradesh , Sun Pharma , Hemang Jani , Aurobindo Pharma , Burger King , Dr Lal Path Lab , Indian School Of Business , Offering College , Tata Motor , Independent Market Expert , Leadership Excellence , Product Officer , Operations Officer , Tata Tech , Tata Technologies , Might Also Like , Jubilant Foodworks , Stocks To Buy , Titan Balrampur Chini , Sugar Prices , Margin Expansion , Experts Stock Ideas , Expert View , Stock Market , Et Now ,

Short Call | Green shoots for Dr Lal, intellect pessimism overdone, gas stocks on fire, raging capex war

In the past, the market has rallied whenever FIIs were net short on the market. Now that they are net long, should this be seen as a contrarian indicator? ....

Shailaja Mohapatra , Bharat Shah , Jim Rogers , Shubham Raj , Madhavi Arora , National Health Mission , Nifty Bank , Metropolis Healthcare , Krsnaa Diagnostics , Lal Path , Design Arena , Short Call , Indian Markets , Diagnostic Stocks , Dr Lal Path Lab , Gas Stock ,

stock recommendations: Jay Thakkar on 2 stocks to buy in short term

“The first buy recommendation is on Metropolis. This stock has provided a breakout from multiples showing resistance. It has formed a good rectangular or a good consolidation base formation at the lower end after falling quite a lot. NMDC is the other candidate which is seeing short covering in this sideways or downtrend market. ” ....

Ajay Thakkar , Dr Lal Path Lab , Bank Nifty To , Bank Nifty , Bank Nifty Midcap , Nifty Bank Index , Head Of Alternate Research , Nifty Bank , Vice President , Alternate Research , Nifty Midcap , Nifty Smallcap , Nifty Midcap Index , Stock Recommendations ,

Q4 results today: Asian Paints, Eicher, Dr Lal Path Lab, Religare among others to report earnings

Otther than several macro economic factors, market will respond to the quarterly results of companies like Asian Paints, Eicher motors, Dr Lal Path Lab, Religare Enterprises, etc set to be announced on Thursday ....

Nexus Select Trust , India Bank , Asian Paints Ltd , Ajmera Realty , Eicher Motors , Everest Industries , Gillette India , Neuland Lab , Religare Enterprises , Mangalore Chemicals , Everest Ind , Shankara Buildings , Paisalo Digital , South India Bank , Gillette India Limited , Lal Path Labs , Eicher Motor , Quarterly Results , Care Ratings , May 11 , Asian Paints , Q4 Results Today , Dr Lal Path Lab ,